Liechtenstein vs Netherlands: Screening rates for cancers in Europe
Liechtenstein
34.3%
in 2022
Netherlands
45.7%
in 2022
Liechtenstein rank
17th
Netherlands rank
15th
Screening rates for cancers in Europe over time
- Liechtenstein
- Netherlands
How they compare
Netherlands currently reports 45.7% against 34.3% in Liechtenstein, a difference of 11.4%.
That makes Netherlands's figure about 1.3 times Liechtenstein's.
Across all 9 years both countries report, Netherlands has been ahead every year.
Liechtenstein ranks 17th and Netherlands ranks 15th of 23 countries.
Netherlands has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Liechtenstein | Netherlands | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 27.8% | 59.8% | 32.0% | Netherlands |
| 2020s | 29.3% | 49.7% | 20.5% | Netherlands |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher screening rates for cancers in europe, Liechtenstein or Netherlands?
- Netherlands, at 45.7% against 34.3% in Liechtenstein as of 2022.
- What is the difference in screening rates for cancers in europe between Liechtenstein and Netherlands?
- 11.4%, with Netherlands ahead.
- How many years of comparable data are there for Liechtenstein and Netherlands?
- 9 years are reported by both, from 2014 to 2022.
- How do Liechtenstein and Netherlands rank globally for screening rates for cancers in europe?
- Liechtenstein ranks 17th and Netherlands ranks 15th of 23 countries.
- Where does this data come from?
- Eurostat (2024) β processed by Our World in Data, published as Screening rates for cancers in Europe. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Share of women aged 20 to 69 years who have been screened for cervical cancer within the previous 3 years.